Apnimed, Inc. (NasdaqGS: APMD)
Health Care · Pharmaceuticals · US
$16.63
-0.89% today · -33.5% 1Y
Apnimed, Inc. (NasdaqGS: APMD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $692.32M and employs 81 people.
Over the last twelve months the share price has lost 33.5%, trading between 14.16 and 35.29.
Tweenvest scores Apnimed, Inc. across four factors: quality 38/100, value 77/100. Its strongest factor is value.
APMD price history
Key figures
- Market cap
- $692.32M
- Revenue (TTM)
- $115.12M
- P/E
- 1.88
- EPS
- -23.76
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $35.29
- 52-week low
- $14.16
- Avg volume (3M)
- —
- Shares outstanding
- 41.63M
- Employees
- 81
- Next earnings
- —
About Apnimed, Inc.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
- ISIN
- US03770Y1073
- Founded
- 2017
- Listed since
- Jul 29, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Wecome Pharmaceutical Company LimitedSZSE: 300878 | $711.35M | CN¥33.43 | -4.49% |
| Youcare Pharmaceutical Group Co., Ltd.SHSE: 688658 | $709.16M | CN¥10.65 | -3.09% |
| Yabao Pharmaceutical Group Co., LtdSHSE: 600351 | $700.74M | CN¥6.76 | -2.17% |
| Hunan Fangsheng Pharmaceutical Co., Ltd.SHSE: 603998 | $696.63M | CN¥10.58 | +0.38% |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.SZSE: 002940 | $690.64M | CN¥23.51 | -4.31% |
| Shandong Wit Dyne Health Co.,Ltd.SZSE: 000915 | $686.82M | CN¥19.55 | +0.67% |
| Sun Pharma Advanced Research Company LimitedNSEI: SPARC | $676.86M | Rs195.84 | -4.86% |
| Shanxi Zhendong Pharmaceutical Co.,LtdSZSE: 300158 | $668.29M | CN¥4.49 | -2.39% |